Insider · CIK 0001008890

ALAFI MOSHE

Reports to the SEC for 3 companies · EMERYVILLE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001008890

Forms 4 and 5

Insider transactions

26 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2017-10-02	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+258K sh	$15.50	+$4M	3,953,270
2016-12-07	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+20.8K sh	$16.14	+$336K	3,695,205
2016-12-06	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+44.2K sh	$16.33	+$721K	3,674,379
2016-11-14	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+34K sh	$14.50	+$493K	3,630,205
2014-12-01	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+1,422 sh	$14.75	+$21K	3,596,205
2014-11-28	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+35K sh	$14.75	+$516K	3,594,783
2014-11-19	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+1,034 sh	$14.25	+$14.7K	3,559,783
2014-11-18	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+3,531 sh	$14.23	+$50.2K	3,558,749
2014-11-14	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+133 sh	$15.07	+$2,004.31	3,555,218
2014-11-13	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+2,200 sh	$15.12	+$33.3K	3,555,085
2014-11-12	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+5,000 sh	$15.23	+$76.2K	3,552,885
2014-11-11	Intra-Cellular Therapies, Inc.P Purchase	10% Owner	PPurchase	+5,000 sh	$15.55	+$77.8K	3,547,885
2014-06-19	Intra-Cellular Therapies, Inc.S Sale	10% Owner	SSale	−15.7K sh	$6.35	−$100K	0
2005-05-26	MOLECULAR DEVICES CORPStock Option (Right to Buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2004-08-17	STXSStereotaxis, Inc.C Conversion	10% Owner	CConversion	+134K sh	—	—	1,887,766
2004-08-17	STXSStereotaxis, Inc.C Conversion	10% Owner	CConversion	+323K sh	—	—	2,210,346
2004-08-17	STXSStereotaxis, Inc. · Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−625K sh	—	—	0
2004-08-17	STXSStereotaxis, Inc. · Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−2.43M sh	—	—	0
2004-08-17	STXSStereotaxis, Inc. · Series D Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.38M sh	—	—	0
2004-08-17	STXSStereotaxis, Inc. · Series D-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.84M sh	—	—	0
2004-08-17	STXSStereotaxis, Inc. · Series D-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−461K sh	—	—	0
2004-08-17	STXSStereotaxis, Inc. · Series E-2 Convertible Preferred StockC Conversion	10% Owner	CConversion	−819K sh	—	—	0
2004-08-17	STXSStereotaxis, Inc.C Conversion	10% Owner	CConversion	+676K sh	—	—	849,182
2004-08-17	STXSStereotaxis, Inc.C Conversion	10% Owner	CConversion	+388K sh	—	—	1,236,686
2004-08-17	STXSStereotaxis, Inc.C Conversion	10% Owner	CConversion	+174K sh	—	—	173,611
2004-08-17	STXSStereotaxis, Inc.C Conversion	10% Owner	CConversion	+517K sh	—	—	1,753,358

Recent filings

Accepted (ET)
Oct 34
ALAFI MOSHE0001209191-17-055370
SEC(opens sec.gov)
Dec 74
Intra-Cellular Therapies, Inc.0001209191-16-153908
SEC(opens sec.gov)
Nov 174
Intra-Cellular Therapies, Inc.0001209191-16-150890
SEC(opens sec.gov)
Dec 34
Intra-Cellular Therapies, Inc.0001181431-14-037799
SEC(opens sec.gov)
Nov 284
Intra-Cellular Therapies, Inc.0001181431-14-037472
SEC(opens sec.gov)
Nov 214
Intra-Cellular Therapies, Inc.0001181431-14-037062
SEC(opens sec.gov)
Nov 184
Intra-Cellular Therapies, Inc.0001181431-14-036723
SEC(opens sec.gov)
Nov 134
Intra-Cellular Therapies, Inc.0001181431-14-036336
SEC(opens sec.gov)
Jul 104
Intra-Cellular Therapies, Inc.0001181431-14-026523
SEC(opens sec.gov)
May 274
MOLECULAR DEVICES CORP0001003113-05-000058
SEC(opens sec.gov)
Aug 194
Stereotaxis, Inc.0000950138-04-000527
SEC(opens sec.gov)

Companies

Address

C/O ALAFI CAPITAL COMPANY, LLC 8 ADMIRAL DRIVE, SUITE 324

EMERYVILLE, CA, 94608